leisure time -WSS

leisure time

author：comprehensive 2025-09-27 12:21:56 - browse：87297

Obesity conference attendees with a pink and blue Wegovy sign hanging from the ceiling above. -- obesity coverage from STAT — Wegovy, the obesity drug, was inescapable at the ObesityWeek conference in Dallas. Elaine Chen

DALLAS — Here at ObesityWeek, one of the largest conferences on obesity, Novo Nordisk and Eli Lilly are displaying more than a dozen studies that together carry the message: Our blockbuster weight loss treatments will be worth it for society.

But experts point out that much of this company-funded research does not include the cost of the drugs themselves, which sell at more than $10,000 per year in the U.S. and are meant to be taken indefinitely.

The two major pharmaceutical companies have seen interest skyrocket for their GLP-1-based drugs like Ozempic, Wegovy, and Mounjaro, a new generation of medications that can cut substantial amounts of weight. But insurance plans have been slow to grant wide access to obesity treatments, concerned that the vast amount of people eligible to take them, along with their high price, could lead to significant financial strain.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： New lawsuit accuses health insurer Cigna of denying claims in bulk

WSS

CDC Director Mandy Cohen on transparency, trust, and health

In rare move, senator releases unverified FBI source report alleging Biden bribe

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Former reverend arrested for allegedly killing 8

UHS says company favors patients whose insurance pays more

This biotech could one day make human eggs from scratch. But first, they’re trying to rethink IVF

explore

leisure time

entertainment

Hepatitis C has a cure — but many Americans still lack access to it

Judge denies Trump's request for new trial in E. Jean Carroll case

Cancer drug shortages should be causing more outrage

How doctors’ personal politics affect patients

Hepatitis C has a cure — but many Americans still lack access to it

Mystery swirls around US soldier who entered North Korea days ago, officials say

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

FDA panel unanimously endorses Eisai’s Alzheimer’s drug Leqembi

Sports medicine is finally prioritizing gender equality

Device maker Teleflex to acquire urology company for $600M

knowledge

The stock market has soared this year, but will it last? Experts weigh in

After a decade, new Gardasil ad campaign gets it (mostly) right

New Alzheimer's drugs heat up race for early detection blood tests

In the gardens at Boston Children's Hospital, families find sanctuary

'Golden Bachelor' Gerry Turner reveals what he wants in a partner and more

What to watch for from Zogenix and Amicus clinical trials

entertainment

explore

knowledge

focus